Serge Goldner
Algemeen Directeur bij CORETECH 5
Actieve functies van Serge Goldner
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CORETECH 5 | Algemeen Directeur | 14-07-2014 | - |
Voorzitter | 14-07-2014 | - | |
Oprichter | 14-07-2014 | - | |
Investor Relations Contact | - | - |
Loopbaan van Serge Goldner
Eerdere bekende functies van Serge Goldner
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Cukierman & Co. Life Sciences
Cukierman & Co. Life Sciences Investment Banks/BrokersFinance Cukierman & Co. Life Sciences engages in the provision of investment banking services to private and public companies in the fields of biotechnology, pharmaceuticals, diagnostics, medical services, and digital health. The company was founded on 2006 and is headquartered in Tel Aviv, Israel. | Oprichter | 01-01-2006 | - |
Corporate Officer/Principal | 01-01-2006 | - | |
IMMUNE PHARMACEUTICALS, INC. | Financieel Directeur/CFO | - | - |
Statistieken
Internationaal
Verenigde Staten | 2 |
Israël | 2 |
Frankrijk | 2 |
Operationeel
Founder | 2 |
Chief Executive Officer | 1 |
Chairman | 1 |
Sectoraal
Health Technology | 2 |
Finance | 2 |
Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CORETECH 5 | Process Industries |
Bedrijven in privébezit | 2 |
---|---|
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Cukierman & Co. Life Sciences
Cukierman & Co. Life Sciences Investment Banks/BrokersFinance Cukierman & Co. Life Sciences engages in the provision of investment banking services to private and public companies in the fields of biotechnology, pharmaceuticals, diagnostics, medical services, and digital health. The company was founded on 2006 and is headquartered in Tel Aviv, Israel. | Finance |
- Beurs
- Insiders
- Serge Goldner
- Ervaring